<DOC>
	<DOCNO>NCT02348697</DOCNO>
	<brief_summary>Non-interventional study evaluate safety efficacy NOVOCART 3D adult adolescent patient full thickness cartilage defect treatment NOVOCART 3D .</brief_summary>
	<brief_title>Non-Interventional Study Evaluate Safety Efficacy NOVOCART 3D Patients With Cartilage Defects</brief_title>
	<detailed_description>A 36-month post treatment follow adverse serious adverse effect well measurement efficacy International Knee Documentation Committee ( IKDC ) Score .</detailed_description>
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>Male female adult patient Children adolescent close epiphysial plate Defect size ≥2.5 ≤10 cm2 postdebridement Localized full thickness articular cartilage defect knee ( Grade 3 &amp; 4 International Cartilage Repair Society ( ICRS ) classification ) Radiologically apparent degenerative joint disease target knee determine Kellgren Lawrence grade &gt; 2 More 2 defect 2 correspond lesion Ankylosis Arthrofibrosis Diffuse chondromalacia Total/subtotal resect meniscus Insufficient Ligament guidance Patella malignement Inflammatory joint disease General cartilage degeneration increase joint deterioration Cancer , present within last 5 year Primary treatment child adolescent open epiphysial plate Chronical infection disease Untreated coagulation disorder Pregnancy lactate Known history allergy ingredients NOVOCART® 3D</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cartilage Defect Knee</keyword>
	<keyword>MACT</keyword>
</DOC>